Leede Financial Has Weak Estimate for TSE:TH FY2026 Earnings

Theratechnologies Inc. ( TSE:TH – Free Report ) – Analysts at Leede Financial lowered their FY2026 earnings estimates for Theratechnologies in a research report issued to clients and investors on Monday, April 14th. Leede Financial analyst D.

Loe now expects that the company will post earnings per share of $0.20 for the year, down from their prior forecast of $0.21.



The consensus estimate for Theratechnologies’ current full-year earnings is $0.03 per share. Leede Financial also issued estimates for Theratechnologies’ FY2027 earnings at $0.

28 EPS. A number of other research analysts have also recently commented on the stock. Research Capitl raised shares of Theratechnologies to a “strong-buy” rating in a report on Friday, February 14th.

Jones Trading raised shares of Theratechnologies from a “hold” rating to a “strong-buy” rating in a research note on Friday, April 11th. Theratechnologies Price Performance Shares of TH stock opened at C$3.58 on Tuesday.

Theratechnologies has a twelve month low of C$1.59 and a twelve month high of C$4.33.

The company has a quick ratio of 0.64, a current ratio of 1.08 and a debt-to-equity ratio of -293.

92. The business has a fifty day simple moving average of C$2.39 and a 200 day simple moving average of C$2.

18. The company has a market cap of C$114.22 million, a P/E ratio of -40.

52, a P/E/G ratio of -8.50 and a beta of 1.73.

About Theratechnologies ( Get Free Report ) Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

Featured Stories Receive News & Ratings for Theratechnologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theratechnologies and related companies with MarketBeat.com's FREE daily email newsletter ..